Skip to content
Services
Data Product Development and Engineering
AI Infrastructure & Engineering
Drug Discovery Computational Services
Research Environment
Consulting
Advisory across infrastructure, data & AI strategy
Data Sourcing & Partnerships
Find, access & connect the right data
Multimodal Data Integration
Unify imaging, omics & clinical data
Data Harmonization & Curation
Standardize & align data across sources
Data Pipelines & ETL
Reproducible ingestion & transformation
Data Automation & FAIRification
Automated, FAIR-compliant data flows
Where to start
Not sure your data is AI-ready?
A fixed-scope Data Journey assessment maps the gaps before you invest in modeling.
Scalable Data Infrastructure with Cloud
Cloud-native infrastructure that scales
AI-native phenotypic profiling platform
Image-analysis infrastructure for HCS
Agentic AI Workflows
Autonomous, orchestrated AI pipelines
AI-Ready Data Architecture
Architect data for AI from the start
Where to start
Not sure your data is AI-ready?
A fixed-scope Data Journey assessment maps the gaps before you invest in modeling.
Target Identification
Evidence-weighted target prioritization
Morphological Profiling
Phenotypic signatures linked to mechanism
Small Molecule Discovery
Multi-parameter compound prioritization
Biologics Discovery & Development
Developability-aware biologics design
Biomarkers
Biomarkers that survive validation
Clinical Research
HIPAA-aligned clinical data foundations
Discovery science
From a long list to a defensible shortlist.
We weight multimodal evidence into decisions your team can defend in review.
Scientific Applications & Data Visualisations
Custom scientific apps & dashboards
AI Model Development & Deployment
Build & deploy discovery-grade models
AI Agent Assistants for Scientists
AI copilots for research teams
Agentic AI Research Environment
An orchestrated agentic research stack
Discovery science
From a long list to a defensible shortlist.
We weight multimodal evidence into decisions your team can defend in review.
Consulting
Strategic guidance across infrastructure, data & AI.
AI readiness assessment
Clarify goals, gaps and priorities.
Architecture direction
Define the right foundation for scale.
Execution roadmap
Turn ideas into clear next steps.
Where to start
Go to Consulting
Explore the offer and book an assessment.
Technology
Ardigen phenAID
Phenotypic profiling platform
Ardigen Targets
Productized target identification
Ardigen Biologics
Binder design to optimized lead
Ardigen Biomarkers
Productized biomarker discovery
Ardigen ArdiOn – AI Engine
The AI engine behind our platforms
Platforms
AI-native technologies, built for discovery.
Productized platforms powered by Ardigen's proprietary AI engine and the AI-LAB loop.
Career
About us
Knowledge hub
Knowledge hub
Knowledge hub
News
Blog
Webinars
Case Studies
Publications
Posters
Topic
Target ID
Small Molecules
Clinical Drug Development
AI & ML
Bioinformatics
Software Engineering
Data Management
Bioinformatics Workflows
Phenotypic Screening
AI for Biologics
Search
Business
News
14 January 2025
Ardigen Joins the NVIDIA Inception Program to Accelerate AI Solutions in Life Sciences
News
10 December 2024
Your monthly AI in biotech digest – December
News
28 November 2024
WEBINAR: AI and HCS in Cancer Research: Case Studies on Faster Target Discovery and Screening
News
12 November 2024
Your monthly AI in biotech digest – November
News
4 November 2024
A new chapter for Ardigen: opening our new office
News
24 October 2024
New Publication: Harnessing AI for Precision Medicine in Colorectal Cancer
News
26 September 2024
Insights from the Society of Biomolecular Imaging & Informatics (SBI2) Conference
News
25 March 2024
Highlights from the nf-core Hackathon at Ardigen’s Krakow Office
News
25 March 2024
New Publication on Decoding Phenotypic Screening: A Collaborative Effort with Janssen Pharmaceutica and Jagiellonian University
News
20 February 2024
Ardigen Appoints New CCO to Accelerate Growth Plans and Become the Top AI CRO Worldwide
News
29 December 2023
Ardigen and Selvita Now Offer Joint Cell Painting Services
News
29 December 2023
New Paper Released by Ardigen and Collaborators: Advances in AI – Powered Histological Evaluation of Crohn’s Disease and Ulcerative Colitis
News
29 December 2023
Ardigen Collaborates on Breakthrough in TCR Therapy Advancements
News
29 December 2023
Ardigen CEO Janusz Homa Recognized Among AI Sector Leaders by Forbes Polska
News
7 March 2023
Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
News
17 November 2022
Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board
News
27 October 2022
Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
News
25 October 2022
Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board
Â
Page
1
Page
2
Page
3
Â
4888